The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy

2009 ◽  
Vol 85 (2) ◽  
pp. 166-170 ◽  
Author(s):  
Qiu-yue Wang ◽  
Qing-hua Guan ◽  
Fen-qin Chen
2018 ◽  
Vol 12 (1) ◽  
pp. 13-19 ◽  
Author(s):  
Athanasios Skarmoutsos ◽  
Ioannis Skarmoutsos ◽  
Ioannis Katafigiotis ◽  
Elisavet Tataki ◽  
Athina Giagini ◽  
...  

Introduction: Although the prostate specific antigen revolutionized the diagnosis of prostate cancer (PCa), it has its limitations. We prospectively examined the potential use of the platelet-derived growth factor-BB (PDGF-BB) as a urine biomarker for the early diagnosis of PCa. Materials and Methods: The urine samples of 118 patients were collected after a prostatic massage and all the patients subsequently underwent ultrasound-guided transrectal biopsy. PDGF-BB was detected in the urine by enzyme-linked immunosorbent assay. Results: Patients with PCa had greater levels of prostate specific antigen and PDGF-BB. Receiver operating characteristic curve analysis showed that the optimal cut-of of PDGF-BB for the prediction of PCa was 1,504.9 with a sensitivity of 60% and a specificity of 51.3%. For a 100 unit increase in PDGF-BB, the likelihood for PCa increased about 4%. Conclusion: PDGF-BB showed a significant predictive ability for PCa. Detection of PDGF-BB in urine with Elisa was easy and improved our diagnostic accuracy in the diagnosis of PCa.


2014 ◽  
Vol 05 (01) ◽  
pp. 11-20 ◽  
Author(s):  
Shinichi Yamauchi ◽  
Satoru Iida ◽  
Megumi Ishiguro ◽  
Toshiaki Ishikawa ◽  
Hiroyuki Uetake ◽  
...  

2003 ◽  
Vol 18 (7) ◽  
pp. 1392-1396 ◽  
Author(s):  
R. G. Langham ◽  
D. J. Kelly ◽  
J. Maguire ◽  
J. P. Dowling ◽  
R. E. Gilbert ◽  
...  

2015 ◽  
Vol 10 (6) ◽  
pp. 3495-3501 ◽  
Author(s):  
NORIHITO OGAWA ◽  
MIKITO INOKUCHI ◽  
YOKO TAKAGI ◽  
HIROFUMI SUGITA ◽  
KEIJI KATO ◽  
...  

2002 ◽  
Vol 282 (1) ◽  
pp. E161-E169 ◽  
Author(s):  
Evangelia Tsiani ◽  
Poli Lekas ◽  
I. George Fantus ◽  
John Dlugosz ◽  
Catharine Whiteside

Mitogen-activated protein kinase (MAPK) p38 is activated in response to stress stimuli and growth factors relevant to the pathogenesis of diabetic nephropathy. We postulated that mesangial cells exposed to high glucose and to endothelin-1 (ET-1), angiotensin II (ANG II), and platelet-derived growth factor (PDGF) demonstrate enhanced p38 activity and subsequent activation of the cAMP responsive element binding (CREB) transcription factor. Primary rat mesangial cells exposed to 5.6 (NG) or 30 mM glucose (HG) or NG plus 24.4 mM sorbitol (osmotic control) for ≤4 days were acutely stimulated with ET-1, ANG II, or PDGF. After 3 days of HG, p38 phosphorylation and kinase activity increased twofold ( P < 0.05 vs. NG, n = 5). No change in p38 activity was observed with sorbitol. In HG, activation of p38 by ET-1, ANG II, or PDGF was enhanced compared with NG and was protein kinase C (PKC) independent. In HG, CREB phosphorylation in response to ET-1, ANG II, and PDGF stimulation was enhanced compared with NG and was abolished by p38 inhibition with SB202190. To conclude, in HG, mesangial cell p38 is activated, which in turn stimulates CREB phosphorylation. Furthermore, in HG, mesangial cell p38 responsiveness to ET-1, ANG II, and PDGF and consequent CREB phosphorylation are enhanced through a PKC-independent pathway, which may contribute to the pathogenesis of diabetic nephropathy.


Sign in / Sign up

Export Citation Format

Share Document